Market Cap
$41.1B
IDXX
IDEXX LABORATORIES INC /DE
$519.61 ▲ +0.36%
Prev close $517.75Market cap$41.1B
ConsensusBuy
12-mo target$701.33 (+35.0%)
▲ Bullish
Analyst conviction 6/10
Insider Selling Cluster (2 insiders)High Impact Filing (7/10)33 New Institutional Positions17 Institutional Exits Biotech & Drug Discovery
Snapshot
The big-picture read on IDXX right now — valuation, ownership and activity at a glance.
Cap Size
Large Cap
Analyst Consensus
Buy (64%)
Inst. Holders
50 funds
Inst. Value
$28.1B
Inst. Activity
33 buys / 17 sells
Insider Activity
$0.00 buy / $18.5M sell
Insider Net $
-$18.5M
Social Sentiment
50° Neutral
SEC Reports
3
Congressional
1 trades
Price chart 30d -3.6%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 7, 2026 dark_pool
Dark Pool: IDXX — 0.5M shares, 29,735 trades
Week starting 2026-09-07. Total ATS volume: 534,332 shares across 29,735 trades.
Sep 4, 2026 Insider
Kingsley Lawrence D acquired via exercise 2,203 shares
Director @ $114.17 ($251.5K)
Sep 4, 2026 Insider
Kingsley Lawrence D sold 2,203 shares
Director @ $532.08 ($1.2M)
Aug 20, 2026 Insider
Aug 4, 2026 SEC Emerson Andrew surrendered for taxes 86 shares
EVP, CFO and Treasurer
IDEXX reported Q2 2026 EPS of $4.27, an 8.5% beat vs consensus of $3.93, on revenue of $1.217B (in line with $1.20B cons
8-K — Impact 7/10
Jun 30, 2026 Inst.
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP — ADD
1,067,078 shares ($561.8M)
Jun 30, 2026 Inst.
May 5, 2026 SEC Fundsmith LLP — TRIM
1,019,887 shares ($536.9M)
IDEXX reported Q1 2026 revenue of $1.141B (+14% YoY) and GAAP EPS of $3.47 (+17% YoY), beating consensus estimates of $1
8-K — Impact 8/10
Analyst ratings buy % -12.3%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
64% rate it Buy or better · 22 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Aug 11, 2026 | Barclays | MAINTAIN | Overweight | 54% |
| Aug 5, 2026 | UBS | MAINTAIN | Neutral | 55% |
| Aug 5, 2026 | Citigroup | MAINTAIN | Neutral | 55% |
| Jul 27, 2026 | UBS | MAINTAIN | Neutral | 55% |
| Apr 28, 2026 | UBS | MAINTAIN | Neutral | 55% |
| Apr 15, 2026 | Citigroup | INITIATE | Neutral | 55% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 7 | 7 | 8 | 0 | 0 | 64% | |
| Aug 1, 2026 | 7 | 7 | 8 | 0 | 0 | 64% | |
| Jul 1, 2026 | 7 | 7 | 8 | 0 | 0 | 64% | |
| Jun 1, 2026 | 7 | 7 | 8 | 0 | 0 | 64% | |
| May 1, 2026 | 7 | 8 | 8 | 0 | 0 | 65% | |
| Apr 1, 2026 | 7 | 9 | 6 | 0 | 0 | 73% | |
| Mar 1, 2026 | 7 | 9 | 6 | 0 | 0 | 73% | |
| Feb 1, 2026 | 7 | 9 | 6 | 0 | 0 | 73% |
Price targets
Where 12 covering analysts think IDXX trades over the next 12 months.
$701.33 +35.0% upside Strong Buy
Current$519.61 Low$470.00 Median$705.00 High$805.00 12 analysts
$470.00$805.00
Analyst rating Buy· 2.2/5 as of Oct 2, 2026
Social media sentiment mood +0.0%
Retail-investor mood aggregated across social media. 0° = very bearish, 100° = very bullish.
50°
Neutral
BearishNeutralBullish
Recent posts
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
3 SEC filing reports analyzed · 2 bullish, 0 bearish, 0 mixed, 1 neutral · avg impact 5.7/10.
BULLISH8-K7/10
IDEXX reported Q2 2026 EPS of $4.27, an 8.5% beat vs consensus of $3.93, on revenue of $1.217B (in l
Aug 4, 2026
BULLISH8-K8/10
IDEXX reported Q1 2026 revenue of $1.141B (+14% YoY) and GAAP EPS of $3.47 (+17% YoY), beating conse
May 5, 2026
NEUTRALDEFA14A2/10
IDXX filed a definitive proxy statement (DEFA14A) for its upcoming shareholder meeting. The filing i
Mar 27, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Sep 7, 2026
dark_pool
Dark Pool: IDXX — 0.5M shares, 29,735 trades
Week starting 2026-09-07. Total ATS volume: 534,332 shares across 29,735 trades.
Aug 31, 2026
dark_pool
Dark Pool: IDXX — 0.7M shares, 36,511 trades
Week starting 2026-08-31. Total ATS volume: 692,182 shares across 36,511 trades.
Aug 24, 2026
dark_pool
Dark Pool: IDXX — 0.5M shares, 28,424 trades
Week starting 2026-08-24. Total ATS volume: 453,868 shares across 28,424 trades.
Aug 17, 2026
dark_pool
Dark Pool: IDXX — 0.7M shares, 35,464 trades
Week starting 2026-08-17. Total ATS volume: 735,302 shares across 35,464 trades.
Aug 10, 2026
dark_pool
Dark Pool: IDXX — 0.7M shares, 35,240 trades
Week starting 2026-08-10. Total ATS volume: 690,208 shares across 35,240 trades.
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $3.70 | $3.37–$3.91 | 8.9% | -0.1% | 3↑ 7↓ | $1.2B | 11 |
| Next Q | $3.36 | $3.09–$3.55 | 9.0% | -0.2% | 1↑ 8↓ | $1.2B | 10 |
| Current FY | $14.83 | $14.46–$15.18 | 13.4% | -0.1% | 11↑ 0↓ | $4.7B | 12 |
| Next FY | $16.74 | $16.07–$17.13 | 12.9% | -0.0% | 11↑ 2↓ | $5.1B | 12 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $3.703 | — |
| 7d ago | $3.707 | -0.005 |
| 30d ago | $3.707 | -0.005 |
| 60d ago | $3.782 | -0.080 |
| 90d ago | $3.783 | -0.080 |
Institutional ownership
Which big funds own IDXX (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $28.1B total value (53,385,946 shares) as of 2026-Q2. Top holders: BlackRock,, VANGUARD, VANGUARD. Net buying activity: 33 institutions added/increased vs 17 reduced.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| BlackRock, Inc. | 8,170,178 | $4.3B | 15.3% | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 5,152,213 | $2.7B | 9.6% | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3,896,521 | $2.1B | 7.3% | — |
| STATE STREET CORP | 3,748,660 | $2.0B | 7.0% | — |
| Invesco Ltd. | 3,611,416 | $1.9B | 6.8% | — |
| GEODE CAPITAL MANAGEMENT, LLC | 2,562,886 | $1.3B | 4.8% | — |
| BAMCO INC /NY/ | 1,976,778 | $1.0B | 3.7% | — |
| MORGAN STANLEY | 1,356,103 | $713.9M | 2.5% | — |
| Bank of New York Mellon Corp | 1,193,343 | $628.2M | 2.2% | — |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1,067,078 | $561.8M | 2.0% | ADD +27.2% |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | ADD | 838,839 | 1,067,078 | +27.2% | $561.8M |
| Fundsmith LLP | TRIM | 1,465,786 | 1,019,887 | -30.4% | $536.9M |
| FMR LLC | DOUBLED | 282,976 | 822,643 | +190.7% | $433.1M |
| AMERICAN CENTURY COMPANIES INC | ADD | 599,931 | 808,358 | +34.7% | $425.6M |
| Alyeska Investment Group, L.P. | ADD | 203,274 | 401,082 | +97.3% | $211.1M |
| NORGES BANK | NEW | — | 353,944 | — | $186.3M |
| BAILLIE GIFFORD & CO | NEW | — | 353,797 | — | $186.3M |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | NEW | — | 336,986 | — | $179.7M |
| Squarepoint Ops LLC | DOUBLED | 100,309 | 315,164 | +214.2% | $165.9M |
| ROYAL BANK OF CANADA | TRIM | 391,704 | 274,340 | -30.0% | $144.4M |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
15 insiders, 50 transactions. Net -$18.5M — $0.00 bought, $18.5M sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 4, 2026 | Kingsley Lawrence D | Director | EXERCISE | 2,203 | $114.17 | $251.5K |
| Sep 4, 2026 | Kingsley Lawrence D | Director | SELL | 2,203 | $532.08 | $1.2M |
| Aug 20, 2026 | Emerson Andrew | EVP, CFO and Treasurer | TAX W/H | 86 | — | — |
| Aug 20, 2026 | Emerson Andrew | EVP, CFO and Treasurer | EXERCISE | 265 | $178.26 | $47.2K |
| Jul 30, 2026 | HOOLEY JOSEPH L | Director | AWARD | 49 | $558.80 | $27.4K |
| Jun 1, 2026 | FENNELL GEORGE | Executive Vice President | TAX W/H | 284 | $566.79 | $161.0K |
| Jun 1, 2026 | FENNELL GEORGE | Executive Vice President | EXERCISE | 639 | — | — |
| May 12, 2026 | Kingsley Lawrence D | Director | AWARD | 75 | — | — |
| May 12, 2026 | Kingsley Lawrence D | Director | AWARD | 168 | — | — |
| May 12, 2026 | ESSIG STUART | Director | AWARD | 525 | — | — |
Congressional trades
IDXX trades disclosed by members of Congress, with disclosure delay.
1 members · 1 buys / 0 sells
| Date | Member | Party | Chamber | Type | Amount | Asset | Disclosed |
|---|---|---|---|---|---|---|---|
| Apr 13, 2026 | Ro Khanna | D | HOUSE | BUY | $1,001 - $15,000 | IDEXX Laboratories Inc | May 13, 2026(31d) |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for IDXX.
Shares short
1,917,016
Settlement Sep 15, 2026
Change vs prior
-8.4%
Semi-monthly cycle
Days to cover
3.8
At avg daily volume
Of shares outstanding
≈2.4%
Estimate — not % of float
All IDXX filing & press-release reports (3)
- 8-K reportAug 4, 2026
- 8-K reportMay 5, 2026
- DEFA14A reportMar 27, 2026